At the completion of this activity, the participant will be able to:
1. Recall the pharmacokinetic (PK) and pharmacodynamics (PD) properties of beta-lactam antibiotics
2. Describe the PK/PD changes that occur in critically ill patients
3. Identify strategies to optimize the administration of beta-lactams in critically ill patients
4. Discuss the relevance of therapeutic monitoring of beta-lactam antibiotics in clinical practice